Warning letterFDA · Dec 21, 2023
Botanical Be MARCS-CMS 671066, December 21, 2023
Named company: Botanical Be
As described below, these products are unapproved new drugs sold in violation of sections 505(a) and 301(d) of the Federal Food, Drug, and Cosmetic Act (FD&C Act), 21 U.S.C. 355(a) and 331(d). Furthermore,…
Lot information: not specified in this record.